Screener
Sionna Therapeutics SION Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 45,075,651 and 44,723,585 shares issued, 45,075,651 and 44,723,585 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 45 | 45 |
| Additional paid-in capital | 571,380 | 562,602 |
| Accumulated other comprehensive (loss) income | (84) | 540 |
| Accumulated deficit | (283,133) | (256,354) |
| Total stockholders’ equity | 288,208 | 306,833 |
| Total liabilities and stockholders’ equity | $305,039 | $325,953 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's total liabilities & equity?
- Sionna Therapeutics (SION) reported total liabilities & equity of $305.04M in Q1 2026.
- How has Sionna Therapeutics's total liabilities & equity changed year-over-year?
- Sionna Therapeutics's total liabilities & equity decreased by 17.5% year-over-year, from $369.67M to $305.04M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Sionna Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude